Labs / Assays & in vitro testing
Porton
Chongqing, China · portonpharma.com
GMP
Porton Pharma Solutions is a CDMO that provides customized R&D and GMP manufacturing services to pharmaceutical and biotech companies and research institutions worldwide. It works across the drug lifecycle from preclinical development to commercialization and serves small molecules, TIDES, biologics and conjugates, and advanced therapy medicinal products. The company has operations in China, the United States, Switzerland, and Belgium.
Their website has a general contact form; we send your quote request through it.
What they offer
Small Molecule CDMO Services
Provides process development and manufacturing for intermediates, drug substances, and drug products, plus quality research and IND/NDA filing support.
Peptide CDMO Services
Offers research, process development and manufacturing, formulation development, drug product manufacturing, analytical method development and validation, and regulatory affairs support for peptide drugs.
Oligonucleotide CDMO Services
Supports oligonucleotide drug development through research, process development and manufacturing, formulation, analytical work, and regulatory support.
Biologics and Conjugates CDMO Services
Provides services for biologics and conjugate products including early research, process development and manufacturing, formulation, analytical method development and validation, and regulatory affairs support.
Advanced Therapy Medicinal Products CRO & CDMO Services
Provides CRO and CDMO services for advanced therapy medicinal products.
Chemical Engineering & Technology
Supports process R&D and manufacturing with capabilities in particle engineering, computation chemistry and data science, material science, catalysis and reaction engineering, and process engineering.
What they work on
- Modalities
- Small molecule, Antibody, ADC, Peptide, Oligonucleotide
- Assays and studies
- analytical method development, analytical method validation, quality research, reaction kinetics, reaction simulation, process simulation
- Instruments and platforms
- Thin Film Evaporator, Column Chromatography, Flow Chemistry, Distillation Column
- Scale and capacity
- ~2,200 total capacity (m³), 1,200+ R&D and TechOps, ~1,080 m³ total capacity at Chongqing Changshou site, Reactor volume ranges from 5 L to 10,000 L, 12 workshops under operation at Chongqing Changshou site
- Type
- CRDMO
- Sites
- South Plainfield, New Jersey, United States · Cranbury, New Jersey, United States · Chongqing, China · Shanghai, China · Jiangxi, China · Hubei, China · Suzhou, Jiangsu, China · Turnhout, Belgium · Switzerland, Switzerland
- Team
- over 4,400 employees globally
- Quality
- FDA · EMA · WHO · NMPA · PMDA
- Serves
- worldwide
- Founded
- 2005
Public records
- FDA establishment
- 3006625990
- FDA drug establishment
- Porton Pharma Solutions Ltd source
- Biocom California CRO directory
- Biologics and Conjugation Service, CMC Development, Drug Product Development and Manufacturing, Peptide and Oligonucleotide CDMO, Small Molecule API CDMO source
- FDA drug establishment registration
- 3006625990 · API MANUFACTURE source
Similar labs. Veranova, ARSI Canada Inc, Aurigene Pharmaceutical Services, WuXi STA
Found in the Biocom California CRO directory, a contract services directory. Listing built from portonpharma.com. Work here? Claim this listing.